Blog

Posted: 09 may 2026

Machine learning reveals two main Parkinson's types and five subgroups

A new study led by researchers from VIB and KU Leuven shows that Parkinson's disease can be divided into distinct subtypes, helping explain why a single treatment does not work for all patients. Using a machine-learning-driven analysis, the team identified…

4basebio announces lease of an innovation hub and manufacturing facility in Cambridge, UK

4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces a significant expansion into a new innovation hub and manufacturing facility in Cambridge, UK, supporting growing demand for research and high-quality grade manufacturing of synthetic…

AHA identifies 10 key factors to lower dementia and stroke risk

The American Heart Association outlined how promoting healthy lifestyle behaviors, improving environmental conditions, and expanding access to health, social, and mental health care can protect brain health and reduce the risk of stroke and dementia. Worldwide, the number of people…

AI in cancer research waits for its funding moment

As general-purpose AI like ChatGPT and Gemini make its way into people's everyday lives today, domain-specific ones like AI in cancer are also advancing, with only funding and critical infrastructure standing in the way of clinical use, according to one…

AI won’t fix healthcare until we fix the infrastructure

Infrastructure is easy to overlook and underinvest in. Roads, bridges, and electrical grids fade into the background, until a failure makes them impossible to ignore. The same is becoming true for AI in healthcare. Over the past several years, health…

AI tool pinpoints high-risk cancer cells

Researchers at McGill University have developed an AI tool that can identify rare groups of cells responsible for driving aggressive cancer progression. The tool, called SIDISH, offers a new way to distinguish which cells within a tumour are most strongly…

Mount Sinai uses AI to enhance the speed of genomic testing

A new platform from Sophia Genetics is helping the health system improve genomic testing workflows and the quality of cancer care, the company says. Read more here.

Click Therapeutics granted FDA market authorization for digital migraine drug

Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines. Read more here.

How Healthcare Organizations Can Go From Technical Debt to a Hybrid Infrastructure That Supports Innovation

Technical debt comes in many forms, especially for hospitals and health systems. The larger the organization, the more complex the technology, explains David Hotchkiss, vice president and chief information and security officer for the Medical College of Wisconsin. Read more here.

Get Involved

On the day